Munich Re's New Floor: Why a Strong Balance Sheet Isn't Enough to Halt the Selloff

Investor confidence in Munich Re is being tested by the pricing cycle in its core reinsurance business, not by any weakness in operational performance. As the stock touched a fresh 52-week low of €452.80 on Friday — down 1.16% on the session — the market's focus is trained squarely on two upcoming investor conferences where management will need to defend its underwriting discipline and capital allocation strategy. Markus Winter, President and CEO of Munich Re America, already fielded questions at the Deutsche Bank Global Financial Services Conference in New York, and CFO Andrew Buchanan is set to appear at Goldman Sachs' 30th European Financials Conference in Zurich on 2-3 June. The message from the trading floor is clear: quarterly results alone no longer reassure.

The core problem lies in the April renewal season. Munich Re's net written premium from renewing contracts fell 18.5% to €2.0 billion, while risk-adjusted prices dropped 3.1%. The company stresses that it walked away from business that failed to meet its return thresholds — a display of pricing discipline that in the short term simply reduces volume. Meanwhile, the broader reinsurance market is seeing capacity increase, driven in part by the growing influence of insurance-linked securities, which gives primary insurers more leverage to push for lower rates. Legal reforms and improved building resilience in the US have further strengthened the hand of cedants, leading to "low double-digit" price declines at the 1 June 2026 renewals. Analysts expect further moderate softening into 2026, even if sector returns remain above cost of capital.

All of this overshadows what on the surface looks like an impressive earnings report. Munich Re's first-quarter group profit surged to €1.714 billion from €1.094 billion a year earlier, with operating earnings reaching €2.230 billion. The property & casualty reinsurance segment alone contributed €841 million, supported by a combined ratio that improved to 66.8% despite insurance revenue slipping to €3.923 billion. The solvency ratio stood at a comfortable 292%, a figure that already accounts for the planned €2.25 billion share buyback. Management has committed to returning over 80% of profits to shareholders via dividends and buybacks; the €24.00 per share dividend for the last financial year went ex-dividend on 30 April 2026.

Should investors sell immediately? Or is it worth buying Münchener Rück?

Yet the stock has fallen 17.52% since the start of the year and 14.44% over the past 30 days alone. Over 12 months the loss is 19.72%. The gap to the 200-day moving average has widened to roughly 15%, confirming a pronounced downtrend. Perhaps most striking is the relative strength index, which sits at 73.9 — a level that would typically signal an overbought market. In the context of a new 52-week low, however, that reading points to an extreme, short-term selling wave rather than any underlying technical strength. The shares now trade about 25% below their 52-week high of €605.00, set last August.

Macro conditions offer little near-term catalyst. The German economy is recovering gradually in 2026, with inflation running between 2.4% and 2.9%, and no further European Central Bank rate hikes are expected. For Munich Re, that means stable but not rising investment income.

The July renewal season therefore becomes the next inflection point. Munich Re expects that the broadly favourable pricing level and the contract terms improvements achieved in recent years can be largely maintained. The market will need to weigh that guidance against the weaker signals from April. Until the half-year financial report on 7 August — or the third-quarter update on 12 November — every comment from management on pricing, volume and underwriting discipline will carry more weight than usual.

For a company with a fortress balance sheet and a record of returning cash to shareholders, the current share price represents a test of faith. Capital management can support demand for the stock, but it cannot replace pricing power in the core reinsurance franchise. Whether the €452.80 level marks a floor depends on how deep the rate cycle cuts — and whether the conversations in Zurich and New York can shift the narrative from softening premiums to disciplined underwriting.

Ad

Münchener Rück Stock: New Analysis - 30 May

Fresh Münchener Rück information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Münchener Rück analysis...

en | DE0008430026 | MUNICH | boerse | 69449621 |